LMR Partners’s Biocept, Inc. BIOC Stock Holding History

LMR Partners’s Portfolio BIOC Stock Details BIOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-1	Closed	-$72K	–	489
2014 Q3	$72K	Sell	1 -1	-50%	-$124K	0.01%	287
2014 Q2	$264K	Sell	2 -1	-33%	-$147K	0.02%	358
2014 Q1	$668K	Buy	+3	New	+$678K	0.09%	101

Other funds holding BIOC

GBA

Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Camelot Portfolios Maumee, Ohio $143M AUM 14.82% 1-Year Est. Return

MFS

MSI Financial Services Springfield, Massachusetts $3.07B AUM 10.22% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LMR Partners's BIOC Position: Q4 2014 in Review

LMR Partners sold out of Biocept, Inc. (BIOC) in Q4 2014, closing a stake of 1 share — an estimated $72K sold.

LMR Partners first reported a position in BIOC in Q1 2014 and held it in 3 quarters. The position peaked at $668K in Q1 2014. 4 funds tracked by Wall St. Rank hold BIOC as of Q4 2014.

LMR Partners reported no remaining Biocept, Inc. position as of Q4 2014 after selling out during the quarter.
LMR Partners sold 1 Biocept, Inc. share in Q4 2014, an estimated $72K.
LMR Partners first reported a position in Biocept, Inc. in Q1 2014 and held it in 3 quarters.
LMR Partners's Biocept, Inc. position peaked at $668K in Q1 2014.
4 funds tracked by Wall St. Rank held Biocept, Inc. as of Q4 2014.

Based on LMR Partners's 13F filing for Q4 2014, filed 20 Jan 2015.